Investors

Who Invested in Latus Bio?
Latus Bio is developing curative AAV gene therapy products for CNS disorders
Angel Investor
Sahin Boydas
Angel Investor · 234+ companies across 37 markets
Investors in Latus Bio include Gaingels and 8VC. Of its investors, these are in the most other companies in Sahin’s portfolio.
Institutional Investors in Latus Bio
- DCVC BioVenture Capital
- BioAdvanceVenture Capital
- 8VCVenture Capital
- Ben Franklin Technology PartnersInvestment Firm
- GaingelsVenture Capital
- Modi VenturesInvestment Firm
- Samsung VenturesCorporate Investor
- Helen’s Pink Sky FoundationInvestor
- KDB Silicon ValleyInvestment Firm
Angel Investor: Sahin Boydas
Sahin Boydas
#1 most active angel investor in the U.S. in 2024 (Lenny's Newsletter)
- Companies
- 234+
- Markets
- 37
- $1B+ Companies
- 46
- Biotech Companies
- 10
Why Angel Investors Matter for Latus Bio
Angel investors like Sahin Boydas provide more than capital to companies like Latus Bio. They bring early-stage validation, industry connections, and strategic guidance that help startups navigate from idea to product-market fit. Latus Bio is part of a broader thesis on the Biotech market, where the public portfolio holds 10 companies in total.
Angel investors typically invest at the earliest stages, when risk is highest but potential returns are greatest. Latus Bio’s progress reflects the early conviction that angel investors placed in the company's vision and team.
This evidence-based directory lists investors in the sources below. It may not be complete.
DCVC Bio
venture firm
BioAdvance
venture firm
venture firm
Ben Franklin Technology Partners
investment firm
venture firm
Modi Ventures
investment firm
Samsung Ventures
corporate investor
Helen’s Pink Sky Foundation
other
KDB Silicon Valley
investment firm
Browse more investors
Other Biotech companies with investors